2022
DOI: 10.3390/pathogens11030370
|View full text |Cite
|
Sign up to set email alerts
|

Repurposing Avasimibe to Inhibit Bacterial Glycosyltransferases

Abstract: We are interested in identifying and characterizing small molecule inhibitors of bacterial virulence factors for their potential use as anti-virulence inhibitors. We identified from high-throughput screening assays a potential activity for avasimibe, a previously characterized acyl-coenzyme A: cholesterol acyltransferase inhibitor, in inhibiting the NleB and SseK arginine glycosyltransferases from Escherichia coli and Salmonella enterica, respectively. Avasimibe inhibited the activity of the Citrobacter rodent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 21 publications
(27 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?